1AI 0.00% 1.0¢ algorae pharmaceuticals limited

Ann: NTCELL and Parkinsons trial update, page-5

  1. 11,411 Posts.
    lightbulb Created with Sketch. 5727
    Plus NT Cell is back as the lead product''
    About Living Cell Technologies Living Cell Technologies Limited (LCT) is an Australasian biotechnology company improving the wellbeing of people with serious diseases worldwide by discovering, developing and commercialising regenerative treatments which restore function using naturally occurring cells.

    LCT’s lead product, NTCELL®, is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. After implantation NTCELL functions as a biological factory, producing factors to promote new central nervous system growth and repair disease-induced nerve degeneration.

    The Phase I/IIa clinical trial of NTCELL for the treatment of Parkinson’s disease, in New Zealand, met the primary endpoint of safety and halted the progression of the disease three years after implant. Results from this trial were used to design a larger Phase IIb trial to confirm the most effective dose of NTCELL, define any placebo component of the response and further identify the initial target Parkinson’s disease patient sub group.
    This trial commenced in March 2016. The 26 week results of this trial require further analysis and patients will continue to be monitored in accordance with the study extension protocol.
    In addition to Parkinson’s disease, NTCELL has the potential to be used in a number of other central nervous system indications, including Huntington’s, Alzheimer’s and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT’s proprietary encapsulation technology, IMMUPEL™, allows cell therapies to be used without the need for co-treatment with drugs that suppress the immune system.

    LCT is listed on the Australian (ASX: LCT) and US (OTCQX: LVCLY) stock exchanges. The company is incorporated in Australia, with its operations based in New Zealand.

    No Mention of Diabecell in the company's material any longer???
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $16.61M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $1.15K 115.0K

Buyers (Bids)

No. Vol. Price($)
12 5779455 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1750608 7
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.9¢
  Change
0.000 ( 10.0 %)
Open High Low Volume
1.0¢ 1.0¢ 0.9¢ 480000
Last updated 15.47pm 29/03/2024 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.